Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Accounts Payables (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Accounts Payables for 6 consecutive years, with $13.7 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accounts Payables fell 50.52% year-over-year to $13.7 million, compared with a TTM value of $13.7 million through Dec 2024, down 50.52%, and an annual FY2024 reading of $13.7 million, down 50.52% over the prior year.
  • Accounts Payables was $13.7 million for Q4 2024 at Cresco Labs, down from $27.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $32.3 million in Q4 2021 and bottomed at $13.7 million in Q4 2024.
  • Average Accounts Payables over 5 years is $25.0 million, with a median of $27.6 million recorded in 2023.
  • The sharpest move saw Accounts Payables plummeted 63.03% in 2020, then surged 38.94% in 2021.
  • Year by year, Accounts Payables stood at $23.2 million in 2020, then surged by 38.94% to $32.3 million in 2021, then dropped by 12.97% to $28.1 million in 2022, then decreased by 1.8% to $27.6 million in 2023, then tumbled by 50.52% to $13.7 million in 2024.
  • Business Quant data shows Accounts Payables for CRLBF at $13.7 million in Q4 2024, $27.6 million in Q4 2023, and $28.1 million in Q4 2022.